New Drug May Cut The Risk Of Heart Disease

Cardiologists have been studying a new drug called polypill, which could see the risk from heart disease greatly decreased with its combination of aspirin and statins.

Preventative medicine is a key area in the lowering of this global health problem.

The research was undertaken over a twelve month period and looked at over two thousand people grouped to cover the combination of different medications typically used in the area of preventative area.

Salim Yusaf, who led the team, explained the main reason for the study was to try and develop a single pill to replace the multitude that can be taken by a single patient.

The resulting data seems to indicate that what is often referred to as a ‘super pill’ is possible and is likely to be very effective.

Researchers found that the polypill reduced blood pressure just as well as a combination of up to three different medicines. Furthermore, the reduction of LDL cholesterol was higher than in almost every other group.

A leading cardiologist from Harvard University, Dr Christopher Cannon proclaimed that it was taking the world of medicine a step closer to the major issue of beating heart problems. Of the total case of the disease, over eighty percent is treated in third world countries.

This very simplistic concept could ultimately save thousands of lives and so far, the only side effects found with the polypill were no different to those normally associated with heart preventative medications.

In fact, heart rates from those taking the polypill dropped by 7bpm more than in any other group tested.